» Articles » PMID: 22227739

IL-12 Concentrations in the Aqueous Humor and Serum of Diabetic Retinopathy Patients

Overview
Specialty Ophthalmology
Date 2012 Jan 10
PMID 22227739
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Previous studies suggest that inflammation plays an important part in the pathogenesis of diabetes. Cytokines may have a role in both positive and negative control of immunological reactions. Among many cytokines, interleukin 12 (IL-12) is known to be a strong pro-inflammatory cytokine.

Methods: A total of 76 participants were enrolled in this study and classified into four groups: 23 diabetic patients with non-treated retinopathy, 17 diabetic patients with treated retinopathy, 12 diabetic patients without retinopathy, and 24 healthy control patients. Serum and aqueous humor samples were taken for the analysis of IL-12 concentration.

Results: The aqueous humor IL-12 concentration was significantly elevated in the patients with non-treated diabetic retinopathy (χ(2)(3, n = 76) = 27.137; p < 0.001). No significant differences in IL-12 serum concentrations between the groups were found (F = 0.405, p = 0.750). Correlation analysis of IL-12 concentrations in the serum and aqueous humor showed a linear association between the two variables only in non-diabetic patients (p = 0.003).

Conclusions: This is the first study to show a significantly higher concentration of pro-inflammatory cytokine IL-12 in the aqueous humor of non-treated diabetic retinopathy patients in comparison with diabetic patients treated for retinopathy, without retinopathy, or with healthy individuals. Because the serum levels of IL-12 did not differ considerably between the studied groups, it is plausible that this is due to its local production and secretion.

Citing Articles

Proinflammatory Tear Cytokines in Human Adenoviral Keratoconjunctivitis and Clinical Eye Severity.

Santacruz Valdes C, Ponce-Rosas E, Jimenez-Martinez M Clin Ophthalmol. 2025; 19:439-448.

PMID: 39959881 PMC: 11829603. DOI: 10.2147/OPTH.S497111.


The IL-12 family of cytokines: pathogenetic role in diabetic retinopathy and therapeutic approaches to correction.

Wang D, Liu R Naunyn Schmiedebergs Arch Pharmacol. 2024; 398(1):125-133.

PMID: 39120722 DOI: 10.1007/s00210-024-03360-9.


Biochemical Changes in Anterior Chamber of the Eye in Diabetic Patients-A Review.

Dolar-Szczasny J, Drab A, Rejdak R J Clin Med. 2024; 13(9).

PMID: 38731110 PMC: 11084197. DOI: 10.3390/jcm13092581.


Ocular Vascular Diseases: From Retinal Immune Privilege to Inflammation.

Wang X, Wang T, Lam E, Alvarez D, Sun Y Int J Mol Sci. 2023; 24(15).

PMID: 37569464 PMC: 10418793. DOI: 10.3390/ijms241512090.


Diabetic Retinopathy: Soluble and Imaging Ocular Biomarkers.

Ferrara M, Loda A, Coco G, Grassi P, Cestaro S, Rezzola S J Clin Med. 2023; 12(3).

PMID: 36769560 PMC: 9917666. DOI: 10.3390/jcm12030912.


References
1.
Johnsen-Soriano S, Sancho-Tello M, Arnal E, Navea A, Cervera E, Bosch-Morell F . IL-2 and IFN-gamma in the retina of diabetic rats. Graefes Arch Clin Exp Ophthalmol. 2010; 248(7):985-90. DOI: 10.1007/s00417-009-1289-x. View

2.
. Diabetic retinopathy. Diabetes Care. 2002; 23 Suppl 1:S73-6. View

3.
King G . The role of inflammatory cytokines in diabetes and its complications. J Periodontol. 2008; 79(8 Suppl):1527-34. DOI: 10.1902/jop.2008.080246. View

4.
Schram M, Chaturvedi N, Schalkwijk C, Giorgino F, Ebeling P, Fuller J . Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care. 2003; 26(7):2165-73. DOI: 10.2337/diacare.26.7.2165. View

5.
. A randomized trial of sorbinil, an aldose reductase inhibitor, in diabetic retinopathy. Sorbinil Retinopathy Trial Research Group. Arch Ophthalmol. 1990; 108(9):1234-44. DOI: 10.1001/archopht.1990.01070110050024. View